Navigation Links
Mindray Introduces Enhancements for M Series Ultrasound Platforms at ASA
Date:10/14/2011

MAHWAH, N. J.,Oct. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will be showcasing its newly enhanced hand-held M series ultrasound platforms at the American Society of Anesthesiologists (ASA) conference being held in Chicago between October 14-18, 2011.

The M7 Ultrasound Platform EnhancementsThe M7 platform provides a wealth of advanced imaging features including excellent temporal resolution and innovative multiple-tissue harmonic imaging technologies to improve image quality for technically difficult patients. During the ASA conference, Mindray will be launching the new needle visualization technology, iNeedle, which provides physicians with clear and precise needle detection during procedures. The iNeedle, in conjunction with iZoom, enables users to view patient anatomy more accurately from a distance while iTouch allows for optimized image with a single button. These features help physicians see target structures more clearly and easily for safe and effective anesthetic procedures.

Mindray will also introduce new transducers including the linear array L12-4s and L14-6Ns. The latter are particularly noteworthy because they provide high frequency imaging for nerve and pain management as well as other applications.

"The M7 ultrasound platform has been incredibly well received since the first shipment to North American customers in last June," said Michael Thompson, Vice President of Ultrasound Sales, Mindray North America. "The M7 system elevates hand-carried units (HCU) performance standards to a new level. Due to the highly upgradable system architecture of both the M5 and the M7, we are able to support existing as well as new customers with significant system enhancements and new features introductions."

The M5 Ultrasound Platform Enhancements The company will highlight its popular M5 ultrasound platform, which represents significant value and high performance in a hand-carried device for general ultrasound imaging services. Mindray has released enhancements, such as new transducers, image improvements and other applications, over the past several months.

"Our focus on turning customer insights into meaningful innovations continues with the latest enhancements to the M Series ultrasound platform," said David Gibson, President of Mindray North America.  "We continue to push the frontier of the performance-to-price ratio in order to give clinicians more capabilities in a budget-constrained environment."

About MindrayWe are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com. For investor and media inquiries, please contact:In the U.S.:Hoki LukWestern Bridge, LLCTel:  +1-646-808-9150Email: hoki.luk@westernbridgegroup.com In China:Cathy GaoMindray Medical International LimitedTel:  +86-755-2658-2620Email: cathy.gao@mindray.com
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray Medical to Present at J.P. Morgan China Conference 2010
3. Mindray Medical Provides Mid-Year Update on Product Development
4. Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010
5. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
6. Mindray Launches New Premium M7 Portable Ultrasound System in U.S.
7. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
8. Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference
9. /C O R R E C T I O N - Mindray Medical International Limited /
10. Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer
11. Mindray Medical to Exhibit New Products at 64th China International Medical Equipment Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017 Research and Markets ... Emerging Medical Device Technologies" report to their offering. ... Traditional ... procedures, general instruments, non-drug coated implantables, large endoscopes, needle based ... use over the last two to three decades for the ...
(Date:2/16/2017)... Ontario , Feb. 16, 2017  Aralez Pharmaceuticals ... global specialty pharmaceutical company, today announced that executive management ... Conference to be held February 22-23, 2017. Adrian ... of the Company at 1:35 p.m. local time on ... and audio archive for the event may be accessed ...
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that Vincent J. Angotti ... a member of the company,s board of directors, ... over two decades of experience leading executive and ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... ... Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. ... distinguish between corrective action (CA) and preventive action (PA)? , The methods share ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... GA (PRWEB) , ... February 17, 2017 , ... Like ... to reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program (HRRP), ... been a key focus area for hospitals across the nation. While many providers are ...
(Date:2/16/2017)... York, New York (PRWEB) , ... February 17, ... ... work and determination. After what took over 10 years of research, development and ... technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ingredients ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection ... patient care, NWH has achieved Magnet® recognition for the second time, ... 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet ...
Breaking Medicine News(10 mins):